Joseph Aceto
Corporate Officer/Principal at NEXIEN BIOPHARMA, INC.
Profile
Joseph F.
Aceto is currently the Director at the Pennsylvania Drug Discovery Institute.
He is also serving as Counsel at Obermayer Rebmann Maxwell & Hippel LLP since 2010.
Additionally, he holds the position of Advisor at Nexien BioPharma, Inc. and is the General Counsel & Managing Partner at CRx Bio Holdings LLC.
Previously, Dr. Aceto worked as the Internal Counsel & Director-Intellectual Property at Immunicon Corp.
from 2002 to 2008.
Dr. Aceto completed his education at Drexel University, where he received a graduate degree in 1983.
He also obtained a graduate degree from Widener University School of Law in 2000.
Furthermore, he earned a doctorate degree from Lewis Katz School of Medicine in 1987.
Joseph Aceto active positions
Companies | Position | Start |
---|---|---|
NEXIEN BIOPHARMA, INC. | Corporate Officer/Principal | - |
Obermayer Rebmann Maxwell & Hippel LLP
Obermayer Rebmann Maxwell & Hippel LLP Miscellaneous Commercial ServicesCommercial Services Obermayer Rebmann Maxwell & Hippel LLP offers legal advisory services. Its areas of practice include real estate, intellectual property, banking, insurance, taxation, mergers and acquisitions, bankruptcy, financial reorganization, environmental law, labor, and litigation. It caters to technology companies, regional businesses, banks, insurance and lending institutions, hospital and physician groups, charitable and nonprofit institutions, municipalities, public utilities, and individuals. The company was founded in 1904 and is headquartered in Philadelphia, PA. | General Counsel | 2010-07-31 |
CRx Bio Holdings LLC
CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology CRx Bio Holdings LLC engages in the research and development of advanced cannabinoid therapeutic formulations with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids. The company was founded by Alex Wasyl and is headquartered in Princeton, NJ. | General Counsel | - |
Pennsylvania Drug Discovery Institute | Director/Board Member | - |
Former positions of Joseph Aceto
Companies | Position | End |
---|---|---|
IMMUNICON CORP. | Corporate Officer/Principal | 2007-12-31 |
Training of Joseph Aceto
Lewis Katz School of Medicine | Doctorate Degree |
Drexel University | Graduate Degree |
Widener University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEXIEN BIOPHARMA, INC. | Health Technology |
Private companies | 4 |
---|---|
Obermayer Rebmann Maxwell & Hippel LLP
Obermayer Rebmann Maxwell & Hippel LLP Miscellaneous Commercial ServicesCommercial Services Obermayer Rebmann Maxwell & Hippel LLP offers legal advisory services. Its areas of practice include real estate, intellectual property, banking, insurance, taxation, mergers and acquisitions, bankruptcy, financial reorganization, environmental law, labor, and litigation. It caters to technology companies, regional businesses, banks, insurance and lending institutions, hospital and physician groups, charitable and nonprofit institutions, municipalities, public utilities, and individuals. The company was founded in 1904 and is headquartered in Philadelphia, PA. | Commercial Services |
CRx Bio Holdings LLC
CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology CRx Bio Holdings LLC engages in the research and development of advanced cannabinoid therapeutic formulations with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids. The company was founded by Alex Wasyl and is headquartered in Princeton, NJ. | Health Technology |
Pennsylvania Drug Discovery Institute | |
Immunicon Corp.
Immunicon Corp. Medical SpecialtiesHealth Technology Immunicon Corp. develops, manufactures, markets and sells proprietary cell-based diagnostic and research products and services. It provides services to pharmaceutical and biotechnology companies to develop new therapeutic agents, which focuses on cancer disease management. Immunicon's products and technology platforms have application in cancer research and in other fields of medicine, such as cardiovascular and infectious disease. The company was founded in 1983 and is headquartered in Huntingdon Valley, PA. | Health Technology |
- Stock Market
- Insiders
- Joseph Aceto